Prospects of Innovative Therapeutics in Combating the COVID-19 Pandemic
- PMID: 39085563
- DOI: 10.1007/s12033-024-01240-4
Prospects of Innovative Therapeutics in Combating the COVID-19 Pandemic
Abstract
The sudden global crisis of COVID-19, driven by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), demands swift containment measures due to its rapid spread and numerous problematic mutations, which complicate the establishment of herd immunity. With escalating fatalities across various nations no foreseeable end in sight, there is a pressing need to create swiftly deployable, rapid, cost-effective detection, and treatment methods. While various steps are taken to mitigate the transmission and severity of the disease, vaccination is proven throughout mankind history as the best method to acquire immunity and circumvent the spread of infectious diseases. Nonetheless, relying solely on vaccination might not be adequate to match the relentless viral mutations observed in emerging variants of SARS-CoV-2, including alterations to their RBD domain, acquisition of escape mutations, and potential resistance to antibody binding. Beyond the immune system activation achieved through vaccination, it is crucial to develop new medications or treatment methods to either impede the infection or enhance existing treatment modalities. This review emphasizes innovative treatment strategies that aim to directly disrupt the virus's ability to replicate and spread, which could play a role in ending the SARS-CoV-2 pandemic.
Keywords: Innovative; Mutation; SARS-CoV-2; Therapeutic; Vaccine.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing interest: The authors have no relevant financial or non-financial interests to disclose. Ethical Approval: Not applicable. Consent to Participate: Not applicable. Consent to Publish: Not applicable.
References
-
- Sun, C., & Zhai, Z. (2020). The efficacy of social distance and ventilation effectiveness in preventing COVID-19 transmission. Sustainable Cities and Society, 62, 102390. https://doi.org/10.1016/j.scs.2020.102390 - DOI - PubMed - PMC
-
- Zhao, C., Viana, A., Jr., Wang, Y., Wei, H. Q., Yan, A. H., & Capasso, R. (2020). Otolaryngology during COVID-19: Preventive care and precautionary measures. American Journal of Otolaryngology, 41(4), 102508. https://doi.org/10.1016/j.amjoto.2020.102508 - DOI - PubMed - PMC
-
- Kashte, S., Gulbake, A., El-Amin, S. F., III., & Gupta, A. (2021). COVID-19 vaccines: Rapid development, implications, challenges and future prospects. Human Cell, 34(3), 711–733. https://doi.org/10.1007/s13577-021-00512-4 - DOI - PubMed - PMC
-
- Lamers, M. M., & Haagmans, B. L. (2022). SARS-CoV-2 pathogenesis. Nature Reviews Microbiology, 20(5), 270–284. https://doi.org/10.1038/s41579-022-00713-0 - DOI - PubMed
-
- Hoffmann, M., Kleine-Weber, H., & Pöhlmann, S. (2020). A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Molecular Cell, 78(4), 779–784. https://doi.org/10.1016/j.molcel.2020.04.022 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous